Typical of the hype fueling the rise of obesity drugs is an article from The Economist magazine from earlier this year titled – A new class of drugs for weight loss could end obesity – and subtitled – They promise riches for drugmakers, huge savings for health systems and better lives for millions.
But Marion Nestle (rhymes with vessel – I have nothing to do with the food company Nestle, she says) has her doubts.
She is the NYU public health expert and author of fifteen books, including civic classics Food Politics: How the Food Industry Influences Nutrition and Health (2002) and Soda Politics: Taking on Big Soda (and Winning) (2015).
“What’s going on is that seventy percent of the adult population is overweight or obese,” Nestle told Corporate Crime Reporter in an interview last month. “Dieting is impossible for most people. Eating less and moving more works every time if you can do it. But most people can’t do it. It’s almost impossible for most people. People
— source corporatecrimereporter.com | Sep 13, 2023